Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 300 nM assessed as H3K9 methylation relative to control
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 100 nM assessed as H3K9 methylation relative to control
Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 300 nM assessed as NRAS phosphorylation relative to control
Assay data:1 Active, 1 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 100 nM assessed as NRAS phosphorylation relative to control
Inhibition of STK19 in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 300 nM assessed as H3K9 methylation relative to control
Inhibition of STK19 in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 100 nM assessed as H3K9 methylation relative to control
Inhibition of STK19 in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 300 nM assessed as NRAS phosphorylation relative to control
Inhibition of STK19 in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 100 nM assessed as NRAS phosphorylation relative to control
Inhibition of STK19 in human UACC62 cells expressing wild-type NRAS and BRAF V600E mutant at 1-3 uM assessed as PI3K signaling relative to control
Inhibition of STK19 in human A375 cells expressing wild-type NRAS and BRAF V600E mutant at 1-3 uM assessed as PI3K signaling relative to control
Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as PI3K signaling relative to control
Inhibition of STK19 in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as PI3K signaling relative to control
Inhibition of STK19 in human UACC62 cells expressing wild-type NRAS and BRAF V600E mutant at 1-3 uM assessed as MEK-ERK signaling relative to control
Inhibition of STK19 in human A375 cells expressing wild-type NRAS and BRAF V600E mutant at 1-3 uM assessed as MEK-ERK signaling relative to control
Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as MEK-ERK signaling relative to control
Inhibition of STK19 in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as MEK-ERK signaling relative to control
Inhibition of STK19 in human UACC62 cells expressing wild-type NRAS and BRAF V600E mutant at 1-3 uM assessed as NRAS signaling relative to control
Inhibition of STK19 in human A375 cells expressing wild-type NRAS and BRAF V600E mutant at 1-3 uM assessed as NRAS signaling relative to control
Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as NRAS signaling relative to control
Inhibition of STK19 in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as NRAS signaling relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on